Jingfeng Group

Hainan Jingfeng Pharmaceutical Co., Ltd. is a prominent Chinese pharmaceutical enterprise specializing in the development, manufacturing, and marketing of a diverse range of medical products. The company's core business focuses on high-growth therapeutic areas, including cardiovascular and cerebrovascular health, orthopedics, and gynecology. Its flagship products include Sodium Hyaluronate injections for joint health and various traditional Chinese medicine-based formulations. Jingfeng operates a robust manufacturing network across China and is listed on the Shenzhen Stock Exchange. Despite recent financial restructuring efforts and its ST status, the company remains a significant player in the domestic Chinese pharmaceutical market.